A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

NCT00001302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

NIH

Sponsor class

Conditions

Breast Cancer
Kidney Neoplasm
Lymphoma
Neoplasm Metastasis
Ovarian Cancer

Interventions

DRUG: PSC 833

Sponsor

National Cancer Institute (NCI)